Cover Image
市場調查報告書

Pherecydes Pharma SA - 產品平台分析

Pherecydes Pharma SA - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 310062
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Pherecydes Pharma SA - 產品平台分析 Pherecydes Pharma SA - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 22 Pages
簡介

Pherecydes Pharma SA是配合基於噬菌體技術的治療工具調查、檢測出新產生的細菌之噬菌體的生物製藥公司。該公司的噬菌體相關多樣化程式庫,應用於創造標的系統的替代性替換、微小生物感應器、製藥應用般的生物工學性上。

本報告提供Pherecydes Pharma SA的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關資訊等

Pherecydes Pharma SA的基本資料

Pherecydes Pharma SA概要

  • 主要資訊
  • 企業資料

Pherecydes Pharma SA:R&D概要

  • 主要的治療範圍

Pherecydes Pharma SA:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Pherecydes Pharma SA:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 藥物研發中的產品/聯合治療模式

Pherecydes Pharma SA:藥物簡介

  • PP-0121
  • PP-1131
  • Drug for Bone/Joint Infection
  • Drug for Respiratory Tract Infections
  • 各給藥途徑
  • 各分子類型

Pherecydes Pharma SA:最近的開發平台趨勢

Pherecydes Pharma SA:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06931CDB

Summary

Global Markets Direct's, 'Pherecydes Pharma SA - Product Pipeline Review - 2015', provides an overview of the Pherecydes Pharma SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pherecydes Pharma SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Pherecydes Pharma SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Pherecydes Pharma SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Pherecydes Pharma SA's pipeline products

Reasons to buy

  • Evaluate Pherecydes Pharma SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Pherecydes Pharma SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Pherecydes Pharma SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Pherecydes Pharma SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pherecydes Pharma SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Pherecydes Pharma SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Pherecydes Pharma SA Snapshot
    • Pherecydes Pharma SA Overview
    • Key Information
    • Key Facts
  • Pherecydes Pharma SA - Research and Development Overview
    • Key Therapeutic Areas
  • Pherecydes Pharma SA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Pherecydes Pharma SA - Pipeline Products Glance
    • Pherecydes Pharma SA - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Pherecydes Pharma SA - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Pherecydes Pharma SA - Drug Profiles
    • PP-0121
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PP-1131
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Bone/Joint Infection
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Respiratory Tract Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Pherecydes Pharma SA - Pipeline Analysis
    • Pherecydes Pharma SA - Pipeline Products by Route of Administration
    • Pherecydes Pharma SA - Pipeline Products by Molecule Type
  • Pherecydes Pharma SA - Recent Pipeline Updates
  • Pherecydes Pharma SA - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Pherecydes Pharma SA, Key Information
  • Pherecydes Pharma SA, Key Facts
  • Pherecydes Pharma SA - Pipeline by Indication, 2015
  • Pherecydes Pharma SA - Pipeline by Stage of Development, 2015
  • Pherecydes Pharma SA - Monotherapy Products in Pipeline, 2015
  • Pherecydes Pharma SA - Phase I, 2015
  • Pherecydes Pharma SA - Discovery, 2015
  • Pherecydes Pharma SA - Pipeline by Route of Administration, 2015
  • Pherecydes Pharma SA - Pipeline by Molecule Type, 2015
  • Pherecydes Pharma SA - Recent Pipeline Updates, 2015

List of Figures

  • Pherecydes Pharma SA - Pipeline by Top 10 Indication, 2015
  • Pherecydes Pharma SA - Pipeline by Stage of Development, 2015
  • Pherecydes Pharma SA - Monotherapy Products in Pipeline, 2015
  • Pherecydes Pharma SA - Pipeline by Top 10 Molecule Type, 2015
Back to Top